Prevalence and cost of insomnia in a state Medicaid fee-for-service population based on diagnostic codes and prescription utilization

Sleep Medicine

Volumn 11, Issue 5, 2010, Pages 462-469

  Roy, Anuja N ^a   Smith, Michael ^b  

^a TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

^b UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

Comorbidities; Costs; Insomnia; Medicaid; Prescription utilization; Prevalence

Indexed keywords

BENZODIAZEPINE DERIVATIVE; ESTAZOLAM; FLURAZEPAM; QUAZEPAM; TEMAZEPAM; TRAZODONE; ZALEPLON; ZOLPIDEM;

ADULT; AGED; ARTICLE; CAUCASIAN; COST OF ILLNESS; DEMOGRAPHY; DESCRIPTIVE RESEARCH; DIAGNOSTIC TEST; DRUG COST; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MEDICAID; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; UNITED STATES;

ADOLESCENT; ADULT; ANTI-ANXIETY AGENTS; CHILD; CHILD, PRESCHOOL; COMORBIDITY; DIAGNOSIS-RELATED GROUPS; DRUG PRESCRIPTIONS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEE-FOR-SERVICE PLANS; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; INFANT; INFANT, NEWBORN; MALE; MEDICAID; MIDDLE AGED; PREVALENCE; PYRIDINES; SLEEP INITIATION AND MAINTENANCE DISORDERS; TRAZODONE; UNITED STATES; WEST VIRGINIA; YOUNG ADULT;

EID: 77951649595     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sleep.2009.09.012     Document Type: Article

References (55)

1. Doghramji P.P. Recognizing sleep disorders in a primary care setting. J Clin Psychiatry 2004, 65(Suppl. 16):23-26.
2. Drake C.L., Roehrs T., Roth T. Insomnia causes, consequences, and therapeutics: an overview. Depress Anxiety 2003, 18:163-176.
3. Leger D. Public health and insomnia: economic impact. Sleep 2000, 23(3):S69-S76.
4. Ancoli-Israel S., Roth T. Characteristics of insomnia in the United States: results of the 1991 National Sleep Foundation survey. I. Sleep 1999, 22(Suppl. 2):S347-S353.
5. Ford D.E., Kamerow D.B. Epidemiologic study of sleep disturbances and psychiatric disorders: an opportunity for prevention?. JAMA 1989, 262:1479-1484.
6. Sateia M.J., Doghramji K., Hauri P.J., Morin C.M. Evaluation of chronic insomnia: an American Academy of Sleep Medicine review. Sleep 2000, 23:243-308.
7. State-of-the-science conference statement on manifestations and management of chronic insomnia in adults; June 13-15, 2005. Sleep 2005, 28:1049-1057. National Institutes of Health.
8. Doghramji K. The epidemiology and diagnosis of insomnia. Am J Manag Care 2006, 12:S214-S220.
9. Morin C.M. The nature of insomnia and the need to refine our diagnostic criteria. Psychosom Med 2000, 62:483-485.
10. Ohayon M.M. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev 2002, 6(2):97-111.
11. Roth T., Roehrs T., Costa e Silva J.A., et al. Public health and insomnia: consensus statement regarding its status and needs for future actions. Sleep 1999, 22(Suppl. 3):S417-S420.
12. Roth T., Roehrs T. Insomnia: epidemiology, characteristics, and consequences. Clin Cornerstone 2003, 5(3):5-15.
13. Culpepper L. Secondary insomnia in the primary care setting: review of diagnosis, treatment, and management. Curr Med Res Opin 2006, 22(7):1257-1268.
14. Walsh J.K. Pharmacologic management of insomnia. J Clin Psychiatry 2004, 65(Suppl. 16):41-45.
15. Insomnia assessment and management in primary care. Sleep 1999, 22(Suppl. 2):S402-S412. National Center on Sleep Disorders Research Working Group on Insomnia, NHLBI.
16. Krystal A.D., Roth T. Definitions, measurements, and management in insomnia. J Clin Psychiatry 2004, 65(Suppl. 8):5-7.
17. Leigh P. Employee and job attributes and predictors of absenteeism in a national sample of workers: the importance of health and dangerous working conditions. Soc Sci Med 1991, 33:127-131.
18. Weyerer S., Dilling H. Prevalence and treatment of insomnia in the community: results from the upper bavarian field study. Sleep 1991, 14:392-398.
19. Balter M.B., Uhlenhut E.H. New epidemiologic findings about insomnia and its treatment. J Clin Psychiatry 1997, 171:382-388.
20. Walsh J.K., Engelhardt C. The direct economic costs of insomnia in the United States for 1995. Sleep 1999, 22(Suppl. 2):S386-S393.
21. Stoller M.K. Economic effects of insomnia. Clin Ther 1994, 16(5):873-897.
22. Benca R.M. Diagnosis and treatment of chronic insomnia: a review. Psychiatry Serv 2005, 56(3):332-343.
23. Winkelman J., Pies R. Current patterns and future directions in the treatment of insomnia. Ann Clin Psychiatry 2005, 17(1):31-40.
24. Rosenberg R.P. Sleep maintenance insomnia: strengths and weaknesses of current pharmacologic therapies. Ann Clin Psychiatry 2006, 18(1):49-56.
25. Roth T. Prevalence, associated risks, and treatment patterns of insomnia. J Clin Psychiatry 2005, 66(Suppl. 9):10-13.
26. Morin K.A. Strategies for treating chronic insomnia. Am J Manag Care 2006, 12:S230-S245.
27. Bixler E.O., Kales A., Soldatos C.R., Kales J.D., Healy S. Prevalence of sleep disorders in the Los Angeles metropolitan area. Am J Psychiatry 1979, 136(10):1257-1262.
28. Ohayon M.M., Caulet M., Guilleminault C. Complaints about nocturnal sleep: how a general population perceives its sleep and how this relates to the complaint of insomnia. Sleep 1997, 20:715-723.
29. Newman A.B., Enright P.L., Manolio T.A., Haponik E.F., Wahl P.W. Sleep disturbance, psychosocial correlates, and cardiovascular disease in 5201 older adults: the cardiovascular health study. J Am Geriatr Soc 1997, 45(1):1-7.
30. Ancoli-Israel S., Roth T. Characteristics of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. I. Sleep 1999, 22(Suppl. 2):S347-S353.
31. Kim K., Uchiyama M., Okawa M., Liu X., Ogihara R. An epidemiological study of insomnia among the Japanese general population. Sleep 2000, 23:41-47.
32. Nadolski N. Getting a good night's sleep: diagnosing and treating insomnia. Plast Surg Nurs 2005, 25(4):167-173.
33. Pete Fullerton D.S. The economic impact of insomnia in managed care: a clearer picture emerges. Am J Manag Care 2006, 12:S246-S252.
34. McCall W.V., Fleischer A.B., Feldman S.R. Diagnostic codes associated with hypnotic medications during outpatient physician-patient encounters in the United States from 1990-1998. Sleep 2002, 25(2):221-223.
35. Hays R.D., Stewart A.L. Sleep measures. Measuring functioning and well-being. The medical outcomes study approach 1992, 235-259. Duke University Press, Durham and London. A.L. Stewart, J.E. Ware (Eds.).
36. Balkrishnan R., Rasu R.S., Rajagopalan R. Physician and patient determinants of pharmacologic treatment of sleep difficulties in outpatient settings in the United States. Sleep 2005, 28(6):715-719.
37. Radecki S.E., Brunton S.A. Management of insomnia in office-based practice. National prevalence and therapeutic patterns. Arch Fam Med 1993, 2(11):1129-1134.
38. Morlock R.J., Tan M., Mitchell D.Y. Patient characteristics and patterns of drug use for sleep complaints in the United States: analysis of National Ambulatory Medical Survey data, 1997-2002. Clin Ther 2006, 28(7):1044-1053.
39. Ohayon M. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev 2002, 6(2):97-111.
40. Walsh J.K. Clinical and socioeconomic correlates of insomnia. J Clin Psychiatry 2004, 65(Suppl. 8):13-19.
41. Roth T. New developments for treating sleep disorders. J Clin Psychiatry 2001, 62(Suppl. 10):3-4.
42. Ancoli-Israel S. The impact and prevalence of chronic insomnia and other sleep disturbances associated with chronic illness. Am J Manag Care 2006, 12:S221-S229.
43. Drake C.L., Roehrs T., Roth T. Insomnia causes, consequences, and therapeutics: an overview. Depress Anxiety 2003, 18:163-176.
44. Ford D.E., Kamerow D.B. Epidemiologic study of sleep disturbances and psychiatric disorders: an opportunity for prevention?. JAMA 1989, 262:1479-1484.
45. Ohayon M.M. Prevalence of DSM-IV diagnostic criteria of insomnia: distinguishing between insomnia reltade to mental disorders from sleep disorders. J Psychiatry Res 1997, 31:333-346.
46. Ohayon M., Smirne S. Prevalence and consequences of insomnia disorders. Sleep Med 2002, 3(2):115-120.
47. Johnson E.O., Roehrs T., Roth T., Breslau N. Epidemiology of alcohol and medication as aids to sleep in early adulthood. Sleep 1998, 21(2):178-186.
48. Walsh J.K., Schweitzer P.K. Ten-year trends in the pharmacological treatment of insomnia. Sleep 1999, 22:371-375.
49. Thase M.E. Correlates and consequences of chronic insomnia. Gen Hosp Psychiatry 2005, 27:100-112.
50. Benca R.M., Ancoli-Israel S., Moldofsky H. Special considerations in insomnia diagnosis and management: depressed, elderly, and chronic pain populations. J Clin Psychiatry 2004, 65(Suppl. 8):26-35.
51. Chokroverty S. Diagnosis and treatment of sleep disorders caused by co-morbid disease. Neurology 2000, 54(Suppl. 1):S8-S15.
52. Ancoli-Israel S. The impact and prevalence of chronic insomnia and other sleep disturbances associated with chronic illness. Am J Manag Care 2006, 12(Suppl. 8):S221-S229.
53. Hajak G. Insomnia in primary care. Sleep 2000, 23(Suppl. 3):S54-S63.
54. Kupfer D.J. Pathophysiology and management of insomnia during depression. Ann Clin Psychiatry 1999, 11(4):267-276.
55. Morlock R.J., Tan M., Mitchell D.Y. Atient characteristics and patterns of drug use for sleep complaints in the United States: analysis of national ambulatory medical survey data, 1997-2002. Clin Ther 2006, 28(7):1044-1053.